Plasma/Serum Circulating and Exosomal RNA Purification Kits (Slurry Format)
For rapid and simple isolation of circulating RNA including exosomal RNA from plasma/serum samples
For research use only and NOT intended for in vitro diagnostics.
Plasma/Serum Circulating and Exosomal RNA Purification Kits (Slurry Format)
For rapid and simple isolation of circulating RNA including exosomal RNA from plasma/serum samples
Register today to receive an exclusive 15% off* on your first order.
Overview
- Isolate all sizes of circulating and exosomal RNA, including microRNA
- Versatile plasma and serum input volumes
- Concentrate circulating and exosomal RNA into small elution volumes
- Isolate inhibitor-free circulating and exosomal RNA
- Bind and elute all RNA irrespective of size or GC content, without bias
- Available in Spin Column or 96-well plate formats
- Process 96-well plates using vacuum or centrifugation
- Purified RNA is suitable for a variety of downstream applications, including Small RNA Sequencing. Find out more information on Norgen's NGS services
- Compatible with Streck Cell-Free RNA BCT® Tubes
- Purification is based on Norgen’s proprietary resin matrix
These kits are able to isolate all sizes of circulating and exosomal RNA, including microRNA, without the use of phenol or chloroform. The slurry format provides an advantage over other available kits in that it does not require extension tubes for the purification of free-circulating and exosomal RNA from large sample volumes. RNA can be isolated from either fresh or frozen samples using this kit. This kit is suitable for the isolation of RNA from serum or plasma prepared from blood collected only on either EDTA or citrate. Plasma samples prepared from blood collected on heparin should not be used as heparin can significantly interfere with many downstream applications including RT-PCR. The purified plasma/serum free-circulating and exosomal RNA is eluted in an elution solution that is compatible with PCR, qPCR, methylation-sensitive reverse transcription qPCR, reverse transcription PCR, Northern blotting, RNase protection and primer extension, expression array assays, and NGS.
Free-circulating plasma and serum RNA can serve as both tumor- and fetal-specific markers for cancer detection and prenatal diagnosis.
As well, free-circulating RNAs have the potential to provide biomarkers for other disease states. Free-circulating RNA in plasma or serum are usually present as short fragments
of less than 1000nt, and free-circulating miRNA (21nt) can also be found in plasma and serum.
Plasma/Serum Circulating and Exosomal RNA Purification Kit (Slurry)
Norgen's Plasma/Serum Circulating and Exosomal RNA Purification Kit (Slurry Format) provides a fast, reliable and simple procedure for isolating circulating RNA and exosomal RNA from plasma and serum samples ranging from 0.25 mL to 5 mL.
Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Mini Slurry)
Norgen's Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) provides a fast, reliable and simple procedure for isolating circulating and exosomal RNA from plasma and serum samples ranging from 0.25 mL to 2 mL.
Plasma/Serum Circulating and Exosomal RNA Purification 96-Well Kit (High Throughput Slurry)
Norgen's Plasma/Serum Circulating and Exosomal RNA Purification 96-Well Kit (Slurry Format) provides a high throughput method for isolating circulating and exosomal RNA from plasma and serum samples using either a vacuum manifold or centrifugation.
Plasma/Serum Circulating and Exosomal RNA Purification Maxi Kit (Maxi Slurry)
Norgen's Plasma/Serum Circulating and Exosomal RNA Purification Maxi Kit (Slurry Format) provides a fast, reliable and simple procedure for isolating circulating RNA and exosomal RNA from various amounts of plasma/serum ranging from 2 mL to 5 mL.
Details
Supporting Data
Kit Specifications - Spin Column
|
|
Minimum Plasma/Serum Input
|
0.25 mL
|
Maximum Plasma/Serum Input |
2 mL
|
Size of RNA Purified |
All sizes, including
microRNA |
Time to Complete Purification |
< 40 minutes
|
Cat.51000 Storage Conditions and Product Stability
It is recommended to warm up Slurry C1 and Lysis Buffer A for 20 minutes at 60°C if any salt precipitation (crystallization) is observed. Slurry C1 contains grey resin that will not disappear by warming up.
Component | Cat. 51000 (50 preps) | Cat. 29500 (96 preps) | Cat. 42800 (50 preps) | Cat. 50900 (25 preps) |
---|---|---|---|---|
Slurry C1 | - | - | - | 6 mL |
Slurry C2 | 12 mL | - | 12 mL | - |
Slurry C3 | - | 20 mL | - | - |
Lysis Buffer A | 2 x 130 mL | 4 x 100 mL | 2 x 130 mL | 2 x 130 mL |
Wash Solution A | 38 mL | 2 x 38 mL | 38 mL | 18 mL |
Elution Solution A | 6 mL | 20 mL | 6 mL | 6 mL |
Mini Filter Spin Columns | 50 | - | 50 | 25 |
96-Well Filter Plate | - | 1 | - | - |
Adhesive Tape | - | 1 | - | - |
Collection Tubes | 50 | - | 50 | 25 |
96-Well Collection Plate | - | 1 | - | - |
Elution Tubes (1.7 mL) | 50 | - | 50 | 25 |
96-Well Elution Plate | - | 1 | - | - |
Product Insert | 1 | 1 | 1 | 1 |
Documentation
42800 - Plasma_Serum Circulating and Exosomal RNA Purification Kit (Slurry Format) - SDS
29500 - Plasma_Serum Circulating and Exosomal RNA Purification 96-Well Kit (Slurry Format) - SDS
50900 - Plasma_Serum Circulating and Exosomal RNA Purification Maxi Kit (Slurry Format) - SDS
FAQs
Mini Slurry
Slurry
High Throughput Slurry
- There was an insufficient vacuum. Ensure that a vacuum pressure of at least -650 mbar or -25 inHg is developed
- The centrifuge temperature was too low. Ensure that the centrifuge remains at room temperature throughout the procedure. Temperatures below 15°C may cause precipitates to form that can cause the wells to clog.
- RNase contamination
RNases may be introduced during the use of the kit. Ensure proper procedures are followed when working with RNA. Please refer to “Working with RNA” at the beginning of the protocol's user guide.
- Procedure not performed quickly enough
In order to maintain the integrity of the RNA, it is important that the procedure be performed quickly
Citations
Title | Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood |
Citation | Journal of Extracellular Vesicles 2023. |
Authors | L Cheng, RA Sharples, BJ Scicluna, AF Hill |
Title | Identification and Functional Analysis of Serum Specific miRNAs in Recurrent Aphthous Stomatitis Patients with Excess-heat or Yin-deficiency |
Citation | Clinical Complementary Medicine and Pharmacology 2023. |
Authors | Jie Bao a, Zhengyang Zhu b, Xizhao Zhang c, Lin Huang a, Li Xu a, Xiaobing Dou d, Yongsheng Fan a |
Title | Identification of target genes and pathways related to heat tolerance in Chinese Holstein cows |
Citation | Livestock Science 2023. |
Authors | Rongling Li, Muhammad Jamil Ahmad, Minghai Hou, Xiao Wang, Shenhe Liu, Jianbin Li, Qiang Jiang, Jinming Huang, Liguo Yang |
Title | Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches |
Citation | Methods 2023. |
Authors | N Zarovni, A Corrado, P Guazzi, D Zocco, E Lari, G Radano, J Muhhina, C Fondelli, J Gavrilova, A Chiesi |
Title | Loa loa and Onchocerca ochengi miRNAs detected in host circulation |
Citation | Molecular & Biochemical Parasitology 2023. |
Authors | L Tritten, M O'Neill, S Wanji, A Njouendoui, F Fombad, J Kengne-Ouaffo, C Mackenzie, T Geary |
Title | MALAT1 in Liquid Biopsy: The Diagnostic and Prognostic Promise for Colorectal Cancer and Adenomas? |
Citation | International Journal of General Medicine 2023. |
Authors | Klara Cervena, Anna Siskova, Jiri Jungwirth, Marin Volaric, Jan Kral, Pavel Kohout, Miroslav Levy and Veronika Vymetalkova |
Title | microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection |
Citation | Scientific Reports 2023. |
Authors | Hamam, R., Ali, A. M., Alsaleh, K. A., Kassem, M., Alfayez, M., Aldahmash, A., & Alajez, N. M. |
Title | MiR-200a/ZEB1 Pathway in Liver Fibrogenesis of Biliary Atresia |
Citation | International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering 2023. |
Authors | Liu, H. Y., Chen, Y. H., Pang, S. Y., Wang, F. H., Peng, X. F., Yang, L. Y., ... & Zhu, B |
Title | Mir-21 and Mir-125b as theranostic biomarkers for epithelial ovarian cancer in Tunisian women |
Citation | African Health Sciences 2023. |
Authors | A Habel, F Nassar, M Itani, H Bouaziz, M Hadj-Ahmed, Z Msheik, M Stayoussef, R Nasr & B Yacoubi-Loueslati |
Title | miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes |
Citation | Translational Oncology 2023. |
Authors | Cecilia Bica a c, Ancuta Jurj a, Antonia Harangus b, Cristina Ciocan a, Alin Moldovan b, Oana Zanoaga a, Claudia Burz d e, Manuela Ferracin f, Lajos Raduly a, Ioana Berindan-Neagoe |